Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism THR-β agonists(Thyroid hormone receptor beta-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Autobahn Therapeutics, Inc.Startup |
Active Organization Autobahn Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Preclinical | US | Autobahn Therapeutics, Inc.Startup | 01 Jan 2022 |